These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29052158)

  • 21. Elicitation of informed general population health state utility values: a review of the literature.
    McTaggart-Cowan H
    Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.
    Paracha N; Thuresson PO; Moreno SG; MacGilchrist KS
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):549-559. PubMed ID: 27574879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health state utility values by cancer stage: a systematic literature review.
    Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC
    Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis.
    Muchadeyi MT; Hernandez-Villafuerte K; Schlander M
    BMC Med Res Methodol; 2022 Nov; 22(1):303. PubMed ID: 36434521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies.
    Ara R; Brazier J; Young T
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):67-75. PubMed ID: 29052159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report.
    Wailoo AJ; Hernandez-Alava M; Manca A; Mejia A; Ray J; Crawford B; Botteman M; Busschbach J
    Value Health; 2017 Jan; 20(1):18-27. PubMed ID: 28212961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EQ-5D-Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review.
    Golicki D; Jaśkowiak K; Wójcik A; Młyńczak K; Dobrowolska I; Gawrońska A; Basak G; Snarski E; Hołownia-Voloskova M; Jakubczyk M; Niewada M
    Value Health; 2020 Jul; 23(7):953-968. PubMed ID: 32762998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling the Economic Impact of Interventions for Older Populations with Multimorbidity: A Method of Linking Multiple Single-Disease Models.
    Youn JH; Stevenson MD; Thokala P; Payne K; Goddard M
    Med Decis Making; 2019 Oct; 39(7):842-856. PubMed ID: 31431188
    [No Abstract]   [Full Text] [Related]  

  • 32. Systematic review of health state utility values for economic evaluation of colorectal cancer.
    Jeong K; Cairns J
    Health Econ Rev; 2016 Dec; 6(1):36. PubMed ID: 27541298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Identification, Review and Synthesis of Health State Utility Values from the Literature.
    Ara R; Brazier J; Peasgood T; Paisley S
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):43-55. PubMed ID: 29052156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health Utilities for Multiple Sclerosis.
    Hawton A; Green C
    Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
    Carter GC; King DT; Hess LM; Mitchell SA; Taipale KL; Kiiskinen U; Rajan N; Novick D; Liepa AM
    J Med Econ; 2015; 18(11):954-66. PubMed ID: 26212479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Health State Utility Values in Japanese Patients with End-Stage Breast Cancer.
    Iwatani T; Noto S; Tsugawa K
    Curr Oncol; 2021 Oct; 28(5):4203-4212. PubMed ID: 34677274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting utility for joint health states: a general framework and a new nonparametric estimator.
    Bo Hu ; Fu AZ
    Med Decis Making; 2010; 30(5):E29-39. PubMed ID: 20643911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health.
    Goodwin E; Green C
    Appl Health Econ Health Policy; 2016 Apr; 14(2):161-83. PubMed ID: 26818198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-utility analyses of drug therapies in breast cancer: a systematic review.
    Nerich V; Saing S; Gamper EM; Kemmler G; Daval F; Pivot X; Holzner B
    Breast Cancer Res Treat; 2016 Oct; 159(3):407-24. PubMed ID: 27572551
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.